Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea
· Delayed Price · Currency is KRW 3,230.00
+140.00 (4.53%)
Apr 29, 2026, 3:30 PM KST
Cellid, Revenue
In the year 2024, Cellid, had annual revenue of 4.17B KRW. Cellid, had revenue of 1.88B in the quarter ending December 31, 2024.
Revenue
4.17B
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
91.16B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,814.00B |
| Celltrion | 4,162.50B |
| ALTEOGEN | 215.86B |
| Samsung Epis Holdings | 1,510.14B |
| IMB Dx | 5.33B |
| Kukje Pharma | 175.50B |
| Humasis | 30.11B |
| GeneOne Life Science | 23.04B |